RANBP2 and cholangiocarcinoma: To sum up, the SUMOylation of p27kip1, facilitated by RANBP2, fosters the proliferation of cholangiocarcinoma cells, which may serve as a potentially potent therapeutic target in the eradication of cholangiocarcinoma development and relapses.